Doença de Alzheimer: Novas Abordagens Terapêuticas
DOI:
https://doi.org/10.36557/2674-8169.2023v5n4p2270-2278Keywords:
doença de Alzheimer, demencia, neurogeneração, tratamento, proteína β amilóide, novas teraupêuticas, proteína tau fosforiladaAbstract
This article aims to conduct a review of the current medical literature on new treatment perspectives for patients with Alzheimer's Disease. The search engines Google Scholar, Scielo, PubMed, and Web of Science were used to select articles using the keywords "Alzheimer's Disease; dementia; β-amyloid protein; phosphorylated tau protein; neurodegeneration; treatment; new therapies." It is concluded that there are several ongoing important studies capable of altering the disease's progression. However, there are still limited tools for restoring the cognitive capacity of patients, and studies involving multiple therapies are rare.
Downloads
References
-Aisen, P. S., Seubert, P., & Selkoe, D. J. (2015). Amyloid hypothesis of Alzheimer's disease: Progress and challenges. Nature medicine, 21(4), 435-444.
-Chechler, F., & Mandelkow, E. M. (2018). Tau protein: The key to Alzheimer's disease?. Nature reviews. Neuroscience, 19(10), 616-629.
-Goedert, M. (2003). Tau protein and Alzheimer's disease. Nature reviews. Neuroscience, 4(11), 819-829..
-Blennow, K., & Zetterberg, H. (2016). Alzheimer's disease biomarkers: Current status and future perspectives. Nature reviews. Neurology, 12(1), 46-58.
- Novos tratamentos para o Alzheimer: estamos perto da cura? [Internet]. Instituto da Cultura Científica. 2020
- Christ T. Estudo mostra que três vacinas de rotina reduzem o risco de ter Alzheimer [Internet]. Fiocruz. 2023
- Sant'ana N, Henrique P, Filho G, Rios Mendonça R, Kamada M. Terapia antiamiloide: uma nova estratégia para tratamento da doença de Alzheimer [Internet]. 2017.
- Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, et al. Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease. Solfrizzi V, editor. Journal of Alzheimer’s Disease. 2020.
- Langenberg C, et al. Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med. 2023;29(7):1130-1145.
- Wang L, et al. Gene therapy targeting amyloid-beta production reduces amyloid plaque burden and improves memory in Alzheimer's disease mouse models. Nature. 2022;599(7884):603-607.
- Saxena A, et al. Gene therapy reduces amyloid plaques and improves cognition in Alzheimer's disease. Sci Transl Med. 2022;14(615):eabl6466.
- Abordagem multimodal no tratamento da doença de Alzheimer. São Paulo, SP: ABRAz; 2022.
- Multimodal approaches to Alzheimer's disease. Londres, Reino Unido: IADA; 2022.
- Oliveira-Santos J, et al. Physical exercise for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2022;86(2):473-484.
-Barberger-Gateau P, et al. Nutritional factors and cognitive decline in aging: a review of prospective studies. Am J Clin Nutr. 2007;86(2):395-402.
- O'Neil R, et al. Stress management interventions for Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2022;86(2):509-522.7
-Renata Matos Amâncio, Tatiana, Raquel T, Vanessa Alves Costa, Franco V, de A, et al. Efeitos da Terapia de Reposição Hormonal em Pacientes Portadoras da Doença de Alzheimer. Revista Neurociências. 2019.
- Kivipelto M, et al. Multimodal approaches for Alzheimer's disease: a systematic review and network meta-analysis. Lancet Neurol. 2022;21(5):403-413.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Lucas Neves Coelho Filho, Maria Fernanda Drumond Barbosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
